Boniface E, Guérin J C
Service de Pneumologie, Hôpital de la Croix-Rousse, Lyon.
Rev Mal Respir. 1989;6(2):133-40.
From the data of a retrospective study the authors assess the value of pleural symphysis by talc in the symptomatic treatment of recurrent pleural effusion. 300 patients, 254 of whom were suffering from pleural effusion secondary to cancer and 48 of whom had non-cancerous pleural effusion, were subjected to a thoracoscopy under local anaesthetic allowing the instillation of 5-10 mls of talc powder followed by aspiration drainage for 4-8 days. Out of 270 evaluable cases, an immediate positive result (defined as the absence of any recurrence of the pleural effusion at the drainage site) was obtained in 251 cases or 93% +/- 3% (being 92.1% +/- 3.5% of the cases of pleural cancer and 97.7 +/- 4.5% in cases of non-cancerous pleural effusion). At the end of 6 months there was no recurrence of the effusion in 80.6% of cases. There were 19 early failures (7% +/- 3%) and 25 late failures of whom 9 benefitted from a further attempt at a pleural symphysis (either a pleurectomy, or injection of talc in suspension, or new talc therapy by thoracoscopy). On the whole the complications were minor: pain, fever and rarely more serious: empyema in 6 cases and cancerous nodules down the drainage line in 10 cases. There had been 15 deaths (5.3% +/- 2.6%) during the period of drainage in some very weak and fragile patients. Pleural talcage leads to an improvement in dyspnoea in 82% +/- 7.4% of cases and the general condition was improved in 54% +/- 9.8%.(ABSTRACT TRUNCATED AT 250 WORDS)
作者通过一项回顾性研究的数据,评估滑石粉胸膜固定术在复发性胸腔积液对症治疗中的价值。300例患者接受了局部麻醉下的胸腔镜检查,其中254例继发于癌症的胸腔积液患者,48例为非癌性胸腔积液患者,在胸腔镜检查时注入5 - 10毫升滑石粉,随后进行4 - 8天的抽吸引流。在270例可评估病例中,251例(93%±3%)获得了即时阳性结果(定义为引流部位胸腔积液无复发),其中胸膜癌病例为92.1%±3.5%,非癌性胸腔积液病例为97.7%±4.5%。6个月末,80.6%的病例无积液复发。有19例早期失败(7%±3%)和25例晚期失败,其中9例受益于再次胸膜固定术尝试(胸膜切除术、注射悬浮滑石粉或胸腔镜下新的滑石粉治疗)。总体而言,并发症轻微:疼痛、发热,很少有更严重的:6例脓胸,10例引流线上出现癌结节。在引流期间,一些非常虚弱和脆弱的患者中有15例死亡(5.3%±2.6%)。胸膜滑石粉固定术使82%±7.4%的病例呼吸困难得到改善,54%±9.8%的患者总体状况得到改善。(摘要截短至250字)